Shelton Capital Management Repligen Corp Transaction History
Shelton Capital Management
- $3.85 Billion
- Q3 2024
A detailed history of Shelton Capital Management transactions in Repligen Corp stock. As of the latest transaction made, Shelton Capital Management holds 2,039 shares of RGEN stock, worth $306,951. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,039
Previous 2,115
3.59%
Holding current value
$306,951
Previous $266,000
13.91%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding RGEN
# of Institutions
489Shares Held
54.3MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.14 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$962 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$759 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$244 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$214 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.35B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....